| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Chief Operating Officer
1 company
Koenig Sheldon L. is a President And CEO at Esperion Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 2 sells.
Estimated insider holdings value: $4.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2022 | ESPR Esperion Therapeutics, Inc. | President And CEO | Buy | 8,606 | $5.80 | $49,950.08 | +4.5% | +38.9% | -73.3% | |
| Jun 17, 2022 | ESPR Esperion Therapeutics, Inc. | President And CEO | Sell | 4,552 | $4.99 | $22,719.03 | -2.3% | +34.3% | -74.6% | |
| Mar 17, 2022 | ESPR Esperion Therapeutics, Inc. | President And CEO | Sell | 571 | $4.58 | $2,615.18 | -0.3% | +4.5% | -69.6% |